Product
PanCytoVir™
1 clinical trial
1 indication
Indication
Relative BioavailabilityClinical trial
An Open-label, Balanced, Randomized, Two-period, Crossover, Single Dose Study to Compare the Bioavailability of PanCytoVir™ Oral Suspension (100mg/ml), in Healthy, Adult, Human Subjects Under Fed and Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-07-01